drugset / Trial / NCT06714591
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Non-randomizedSequentialOpen-labelTreatment
Summary
The objective of this study to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of BL-M11D1 in patients with relapsed/refractory acute myeloid leukemia.
Timeline
- Start
- 2024-12-19
- Primary completion
- 2026-12-31
- Completion
- 2027-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BL-M11D1 | Unknown | — | Intravenous |